A growing body of evidence suggests that glucagon-like peptide 1 (GLP-1) and its analogues ameliorate experimental diabetes and preserve β-cell mass, protecting β-cells from apoptosis [93–95]. This evidence concerns the gene GCG and diabetes mellitus.